Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Vanoxerine, a New Drug for Terminating Atrial Fibrillation and Flutter
Journal of Cardiovascular Electrophysiology, 10/28/09
Matsumoto N et al. – Vanoxerine effectively terminated induced, sustained AF and AFL in the canine SP model, and produced insignificant or minimal changes in refractoriness, conduction time, or stimulus threshold, consistent with little proarrhythmic risk.
Related Articles
Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09
Relevance Score: 90%
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter
Archives of Internal Medicine, 10/14/09
Relevance Score: 90%
Anticoagulant Management in Patients with Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Relevance Score: 89%
Patient Characteristics Associated With the Choice of Triple Antithrombotic Therapy in Acute Coronary Syndromes
The American Journal of Cardiology, 10/22/09
Relevance Score: 88%
Outcomes in Patients Requiring Cardioversion Following Catheter Ablation of Atrial Fibrillation
Journal of Cardiovascular Electrophysiology, 10/01/09
Relevance Score: 88%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ring-Calcification of Giant Coronary Artery Aneurysm of an 11-Year-Old Child with History of Kawasaki Disease
Pediatric Cardiology, 11/25/09
Cardiac Stress Testing in Women
The Journal for Nurse Practitioners , 11/25/09
Apical Ballooning Syndrome: The Broken Heart Syndrome
The Journal for Nurse Practitioners , 11/25/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Article Search
Sponsor


See Latest Articles


